Journal
CUREUS JOURNAL OF MEDICAL SCIENCE
Volume 14, Issue 8, Pages -Publisher
CUREUS INC
DOI: 10.7759/cureus.27624
Keywords
probiotics; prevention; clostridium difficile; diarrhea; efficacy
Categories
Ask authors/readers for more resources
This review evaluates the efficacy and safety of probiotics in preventing Clostridium difficile-associated diarrhea (CDAD). The study found promising effects of probiotics in preventing CDAD, with safe and well-tolerated outcomes. Further randomized clinical trials with larger sample sizes and different patient groups are needed to better understand the advantages of probiotics and recommend the optimal dosage and duration of treatment.
Clostridium difficile is a bacterium that affects the gastrointestinal tract and is the leading cause of antibiotic-associated diarrhea. A wide range of probiotics has been studied and used to prevent or treat Clostridium difficile-associated diarrhea (CDAD). Probiotics are microorganisms with unique characteristics that suppress dangerous gut bacteria through several mechanisms. The main objective of this study is to evaluate the efficacy and safety of probiotics in the prevention of CDAD. In this literature review, we searched PubMed and Google Scholar databases to gather related articles depending on predetermined eligibility criteria and found 13 papers of different study designs. We found that probiotics have promising effects in preventing CDAD. Additionally, they were safe and well-tolerated. Further randomized clinical trials with larger sample sizes and various patient groups are needed to better understand the advantages of probiotics and recommend the best dose and duration of probiotic treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available